Invention Grant
US08415313B2 Antisense oligomers and methods for inducing immune tolerance and immunosuppression
有权
反义寡聚体和诱导免疫耐受和免疫抑制的方法
- Patent Title: Antisense oligomers and methods for inducing immune tolerance and immunosuppression
- Patent Title (中): 反义寡聚体和诱导免疫耐受和免疫抑制的方法
-
Application No.: US11433033Application Date: 2006-05-11
-
Publication No.: US08415313B2Publication Date: 2013-04-09
- Inventor: Dan V. Mourich , Patrick L. Iversen , Dwight D. Weller
- Applicant: Dan V. Mourich , Patrick L. Iversen , Dwight D. Weller
- Applicant Address: US OR Corvallis
- Assignee: AVI BioPharma, Inc.
- Current Assignee: AVI BioPharma, Inc.
- Current Assignee Address: US OR Corvallis
- Agency: Seed IP Law Group PLLC
- Main IPC: C12N15/11
- IPC: C12N15/11 ; A61K48/00 ; C07H21/02 ; C07H21/04

Abstract:
A method and composition for inducing human dendritic cells to a condition of reduced capacity for antigen-specific activation of T cells, and, in mature dendritic cells, increased production of extracellular IL-10 is disclosed. A population of dendritic cells is exposed to a substantially uncharged antisense compound, including partially positively charged, containing 12-40 subunits and a base sequence effective to hybridize to a target region within the sequence identified by SEQ ID NO:9, to form a duplex structure between the compound and transcript having a Tm of at least 45° C. Formation of the duplex blocks expression of full-length CD86 in the cells, which in turn leads to reduced capacity for antigen-specific activation of T cells, and, in mature dendritic cells, increased production of extracellular IL-10.
Public/Granted literature
- US20060276425A1 Antisense oligomers and methods for inducing immune tolerance and immunosuppression Public/Granted day:2006-12-07
Information query
IPC分类: